AIA Engineering Targets Volume Growth with New Mining Solution After Earnings Beat SpaceX Scrubs Starship Test Flight Eyes Friday Launch for Starship V3 Debut Goldman Sachs Warns Agentic AI Expansion Hinges on Physical Infrastructure Not Just Semiconductors Oil Plunges as US Stocks Hit New Highs Could Bitcoin Follow the SP 500 Rally Portfolio Manager Trims HighFlying Stock After 80 Surge Since April Initiation Market Sentiment Shifts Following Inflation Data Rate Hike Expectations Rise AMTD Q4 2020 Earnings EPS Surges Past Estimates by 8093 DTB Q1 2026 Earnings EPS Falls Short of Expectations Amid Flat Market Response Stepan Company SCL Q1 2026 Earnings EPS Slightly Tops Estimates Revenue Not Disclosed STTK Q1 2026 Earnings Shattuck Labs Reports Narrower Loss Beats EPS Estimates LILAK Q1 2026 Earnings Deep EPS Miss Highlights Persistent Headwinds Modiv Industrial Inc Class C MDV Q1 2026 Earnings Steep EPS Miss and Stock Decline Highlight Challenging Quarter HealthStream HSTM Posts Modest Gain as Shares Test Key Resistance Levels Petrobras PBR Slips 269 as Oil Sector Headwinds Pressure Shares Imunon Inc IMNN Holds Steady at 220 as Trading Activity Reflects Consolidation Aurinia Pharmaceuticals AUPH Retreats Testing Key Support After EarningsDriven Volatility Western Asset InflationLinked Opportunities Income Fund WIW Holds Steady at 850 Slight Uptick Marks Trading Session Manchester City Faces Squad Adjustment as Bernardo Silva Set for Departure After Nine Seasons AL Q4 2025 Earnings EPS Surges Past Estimates by 2389 Smith Nephew SNN Faces Moderate Decline Testing Support at 290 Calumet Inc CLMT Shows Modest Gains as It Tests Resistance Near 36 Worthington Enterprises WOR Holds Steady Above Support as RangeBound Trading Persists Solitario Resources XPL Holds Steady Near Support as Trading Volume Remains Subdued AiRWA Inc YYAI Faces Mild Pullback Amid Sector Rotation Key Support Tested FrontView REIT Inc FVR Slides 151 as Resistance Caps NearTerm Upside AGNC Investment Corp AGNC Edges Higher Key Levels and Market Dynamics Entrada Therapeutics TRDA Edges Higher as Stock Tests Key Support Zone